Biological PsychiatryNeurosciencePeer-reviewed journal article
Integrative analysis identifies key molecular signatures underlying neurodevelopmental deficits in Fragile X Syndrome
Kagistia Hana UtamiiD, Niels Henning SkotteiD, Ana R. Colaço, Nur Amirah Binte Mohammad YusofiD, Bernice SimiD, Xin Yi YeoiD, Han‐Gyu BaeiD, Marta Garcia‐MirallesiD, Carola I. RadulescuiD, Qiyu CheniD, Georgia ChaldaiopoulouiD, Herty LianyiD, Srikanth Nama, Ulla‐Kaisa PeteriiD, Prabha SampathiD, Maija L. CastréniD, Sangyong JungiD, Matthias ManniD, Mahmoud A. PouladiiD
Abstract
Fragile X syndrome (FXS) is an incurable neurodevelopmental disorder with no effective treatment. FXS is caused by epigenetic silencing of FMR1 and loss of FMRP expression. To investigate the consequences of FMRP deficiency in the context of human physiology, we established isogenic FMR1 knockout (FMR1KO) human embryonic stem cells (hESCs). Integrative analysis of the transcriptomic and proteomic profiles of hESC-derived FMRP-deficient neurons revealed several dysregulated pathways important for brain development including processes related to axon development, neurotransmission, and the cell cycle. We functionally validated alterations in a number of these pathways, showing abnormal neural rosette formation and increased neural progenitor cell proliferation in FMR1KO cells. We further demonstrated neurite outgrowth and branching deficits along with impaired electrophysiological network activity in FMRP-deficient neurons. Using isogenic FMR1KO hESC-derived neurons, we reveal key molecular signatures and neurodevelopmental abnormalities arising from loss of FMRP. We anticipate that the FMR1KO hESCs and the neuronal transcriptome and proteome datasets will provide a platform to delineate the pathophysiology of FXS in human neural cells.
- organism: human
- assay: bulk RNA-seq
- assay: proteomics
- research focus: differential expression
- research focus: cell type annotation
- approach: statistical model
- Citations
- 47
- FWCI
- 4.39
- Field percentile
- top 4%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Novel fragile X syndrome 2D and 3D brain models based on human isogenic FMRP-KO iPSCs
Carlo Brighi, Federico Salaris, … Silvia Di Angelantonio·Cell Death and DiseasePeer-reviewed·May 15, 2021
- Transcriptional dysregulation and impaired neuronal activity in FMR1 knock-out and Fragile X patients iPSC-derived models.
Gilles Maussion, Cecilia Rocha, … Thomas M. Durcan·International Journal of Molecular SciencesPeer-reviewed·Oct 5, 2023
- An iPSC model of fragile X syndrome reflects clinical phenotypes and reveals m6A-mediated epi-transcriptomic dysregulation underlying synaptic dysfunction
Lu Lu, Avijite Kumer Sarkar, … Ziyuan Guo·bioRxiv·Oct 14, 2024
- Dysregulation of an H3K79me2-dependent epigenetic barrier impairs neural progenitor cell proliferation and differentiation in Fragile X syndrome
Olivier Dionne, Gabrielle-Lee Gaudreau, … Benoît Laurent·bioRxiv·Aug 31, 2025
- Fragile X syndrome patient-derived neurons developing in the mouse brain show FMR1 -dependent phenotypes
Marine Krzisch, Hao Wu, … Rudolf Jaenisch·Biological PsychiatryPeer-reviewed·Jan 1, 2023
- Impaired ovarian development in a zebrafish fmr1 knockout model
Rita Rani, N. Sushma Sri, … Aarti Sevilimedu·bioRxiv·Feb 10, 2024